CbdMD Current Valuation vs. Return On Asset
| YCBD Stock | USD 0.40 0.03 6.98% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.47 | 0.56 |
|
|
For CbdMD profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CbdMD to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well cbdMD Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CbdMD's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of cbdMD Inc over time as well as its relative position and ranking within its peers.
CbdMD |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.90) | Revenue Per Share 7.06 | Quarterly Revenue Growth (0.15) | Return On Assets (0.16) | Return On Equity (1.35) |
The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
cbdMD Inc Return On Asset vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining CbdMD's current stock value. Our valuation model uses many indicators to compare CbdMD value to that of its competitors to determine the firm's financial worth. cbdMD Inc is rated second in current valuation category among its peers. It is rated below average in return on asset category among its peers . As of December 11, 2024, Return On Assets is expected to decline to -1.71. Comparative valuation analysis is a catch-all technique that is used if you cannot value CbdMD by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.CbdMD Current Valuation vs. Competition
cbdMD Inc is rated second in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 11.79 Billion. CbdMD adds roughly 3.78 Million in current valuation claiming only tiny portion of equities under Health Care industry.
CbdMD Return On Asset vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
CbdMD |
| = | 3.78 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
CbdMD |
| = | -0.16 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CbdMD Return On Asset Comparison
CbdMD is currently under evaluation in return on asset category among its peers.
CbdMD Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in CbdMD, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CbdMD will eventually generate negative long term returns. The profitability progress is the general direction of CbdMD's change in net profit over the period of time. It can combine multiple indicators of CbdMD, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4.5 M | -4.3 M | |
| Interest Income | 57.3 K | 98.9 K | |
| Operating Income | -10.7 M | -10.1 M | |
| Income Before Tax | -20.6 M | -21.7 M | |
| Net Loss | -66.7 M | -63.3 M | |
| Net Loss | -20.6 M | -21.7 M | |
| Income Tax Expense | 15.7 M | 16.5 M | |
| Net Interest Income | 73.3 K | 76.9 K | |
| Net Loss | -20.6 M | -21.7 M | |
| Total Other Income Expense Net | -12.3 M | -12.9 M | |
| Change To Netincome | 63.2 M | 66.3 M | |
| Net Loss | (10.21) | (10.72) | |
| Income Quality | 0.17 | 0.18 | |
| Net Income Per E B T | 0.95 | 1.00 |
CbdMD Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on CbdMD. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CbdMD position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CbdMD's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in CbdMD without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Use Investing Themes to Complement your CbdMD position
In addition to having CbdMD in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Communication Thematic Idea Now
Communication
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Current Watchlist. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
To fully project CbdMD's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of cbdMD Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CbdMD's income statement, its balance sheet, and the statement of cash flows.